Abattis Bioceuticals Corp. Stock Canadian Securities Exchange
Equities
ATT
CA00258G1037
Healthcare Facilities & Services
Sales 2018 | 8.37K 6.1K | Sales 2019 | 357K 260K | Capitalization | 8.62M 6.28M |
---|---|---|---|---|---|
Net income 2018 | -78M -56.8M | Net income 2019 | -3M -2.18M | EV / Sales 2018 | 5,778 x |
Net cash position 2018 | 9.1M 6.62M | Net cash position 2019 | 2.25M 1.64M | EV / Sales 2019 | 17.8 x |
P/E ratio 2018 |
-0.57
x | P/E ratio 2019 |
-2.8
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 99.64% |
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | - | 19-03-31 | |
Patrick Mitchell
COO | Chief Operating Officer | - | 18-10-31 |
Jonathan Danieli
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Cedric Wilson
BRD | Director/Board Member | - | 18-10-18 |
Patrick Mitchell
COO | Chief Operating Officer | - | 18-10-31 |
Director of Finance/CFO | - | 19-03-31 |
1st Jan change | Capi. | |
---|---|---|
+46.09% | 375M | |
+30.93% | 313M | |
+53.49% | 220M | |
-28.99% | 183M | |
+56.76% | 171M | |
-28.57% | 144M | |
+148.33% | 123M | |
+3.85% | 106M | |
+150.00% | 75.33M |